Figure 3From: Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe Deterministic sensitivity analysis: impact of vaccinating boys and girls versus girls only vaccination † when considering the reduction of remaining burden of female and male carcinomas cases and percentage of relative variation versus base case analysis ‡. GNV, gender-neutral vaccination (boys and girls vaccination). †: same coverage rate and duration of protection are assumed to be applied to boys and girls vaccination and girls only vaccination. ‡: boys and girls vaccination (cumulative vaccination coverage rate 70%, lifetime duration of protection).Back to article page